Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Utah Medical Products (UTMD) Profit After Tax (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Profit After Tax data on record, last reported at $2.6 million in Q3 2025.

  • For Q3 2025, Profit After Tax fell 26.16% year-over-year to $2.6 million; the TTM value through Sep 2025 reached $11.6 million, down 23.84%, while the annual FY2024 figure was $2.9 million, 32.31% down from the prior year.
  • Profit After Tax reached $2.6 million in Q3 2025 per UTMD's latest filing, down from $3.0 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $4.6 million in Q4 2022 and bottomed at $2.6 million in Q3 2025.
  • Average Profit After Tax over 5 years is $3.7 million, with a median of $3.9 million recorded in 2023.
  • Peak YoY movement for Profit After Tax: surged 160.93% in 2021, then crashed 32.31% in 2024.
  • A 5-year view of Profit After Tax shows it stood at $4.1 million in 2021, then grew by 10.26% to $4.6 million in 2022, then fell by 5.88% to $4.3 million in 2023, then plummeted by 32.31% to $2.9 million in 2024, then decreased by 9.34% to $2.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Profit After Tax were $2.6 million in Q3 2025, $3.0 million in Q2 2025, and $3.0 million in Q1 2025.